HUMAN FAECAL MATTER
Clinical Stage 0 Cutaneous Melanoma AJCC v8
M.D. Anderson Cancer Centerother_biologicalPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 89/ 100
Competitive context
3 Active assets in the Clinical Stage 0 Cutaneous Melanoma AJCC v8 cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Infliximab Therakos LLC | Phase 2 | B |
Vedolizumab Therakos LLC | Phase 2 | CCC |
FLUDEOXYGLUCOSE Children's Oncology Group | Phase 1 | CC |
Same molecule, other indications
HUMAN FAECAL MATTER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →